AmerisourceBergen
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
AmerisourceBergen will support the distribution of h2o's Apple Watch-enabled prescription digital therapeutic for Parkinson's disease monitoring.
LionBird's new fund launches with $85 million, and AmerisourceBergen reveals a $150 million venture fund.